Need professional-grade analysis? Visit stockanalysis.com
$22.86B
394.17
1,532
N/A
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) trades on SHE in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY23.65, up 3.14% from the previous close.
Over the past year, 000766 has traded between a low of CNY17.40 and a high of CNY29.50. The stock has gained 30.7% over this period. It is currently 19.8% below its 52-week high.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd has a market capitalization of $22.86B, with a price-to-earnings ratio of 394.17.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides bone peptides, protective chemical medicines, cardiovascular and cerebrovascular chinese patent medicines, heat-clearing and detoxifying medicines, and children's respiratory system chinese patent medicines; and Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Xiongdan powder, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases. In addition, the company offers bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction. The company was founded in 1990 and is based in Tonghua, China.
Side-by-side comparison against top Healthcare peers.